Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06401824 |
| Title | Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Maastricht University Medical Center |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | NLD |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| NKI-AvL | Amsterdam | Netherlands | Details | |||
| University Medical Center Groningen | Groningen | Netherlands | Details | |||
| Maastricht University Medical Center | Maastricht | Netherlands | Details |